(Reuters) – Swiss drugmaker Novartis said on Monday a final-stage trial of its Signifor LAR therapy allowed for greater disease control in patients with the...
(Reuters) – Novartis said U.S. health regulators have granted the Swiss drugmaker’s meningitis B vaccine Bexsero breakthrough therapy status. The Basel-based company in a statement...
(Reuters) – Novartis said on Tuesday U.S. regulators have granted breakthrough therapy status for its investigational compound bimagrumab for the potential treatment of patients with sporadic inclusion...
The yoopya.com portal presents worldwide news, covering a large spectrum of content categories including Entertainment, Politics, Sports, Health, Education, Science and Technology and more. Top local and global news in the best possible journalistic quality. We connect users via a free webmail service and innovative.